Investor Presentation

Here's a summary of the investor presentation: **Business Performance:** GSP Crop Science reported strong growth for the nine months ended December 31, 2025. Consolidated revenue rose by 14% to ₹11,146 Million, driven primarily by the domestic B2C segment.

This segment saw increased sales from new products and key brands like PCT-410, Torch, Aurthor, and Runout.

EBITDA grew by 32% to ₹1,538 Million, and PAT increased by 26% to ₹751 Million. **Growth Drivers or Strategy:** The company is strategically focusing on innovation and product development with a strong in-house R&D capability.

They are expanding their product portfolio through new registrations and are initiating work on futuristic insecticide and herbicide active ingredients for early market entry upon patent expiry. **Recent Developments:** GSP Crop Science launched a patented insecticide + fungicide mixture for paddy and introduced two new herbicides for maize and soybean in the Indian market.

They also expanded their sales operations to Kerala. **Key Financial Metrics (if available):** * Consolidated Revenue (9M FY26): ₹11,146 Million (up 14% YoY) * Consolidated EBITDA (9M FY26): ₹1,538 Million (up 32% YoY) * Consolidated PAT (9M FY26): ₹751 Million (up 26% YoY) **Management Commentary / Outlook (if available):** The company is actively pursuing new product registrations in international markets like Brazil, Africa, and the Middle East, aiming to expand its global offerings.

Their export business saw a 20% increase, supported by product sales in Brazil, the USA, and Africa.